Evaluación farmacoeconómica de los medicamentos antihipertensivos de la Farmacia del Centro de Salud Chambo Tipo B en el período 2022

Abstract

This research aimed to evaluate the pharmacoeconomics of antihypertensive drugs in the pharmacy of the Chambo Health Centre type "B" in the year 2022. The research modality was mixed, i.e. quantitative and qualitative, in addition, the methods used were analytical-synthetic, to obtain reasoning and critical thinking related to the phenomena and problems presented throughout the inductive-deductive research, therefore, research and logic were used to reach conclusions from the data obtained. The results obtained related to the research highlight that the economic item in medicines for hypertensive patients is minimal for the 619 patients attended in the indicated period, in the same way, an adequate supply of losartan and enalapril must be guaranteed, manage the proper supply of Amlodipine prioritize its use and efficiently manage the inventory of amlodipine, so it is concluded that the pharmacoeconomic evaluation of antihypertensive drugs of the pharmacy of the Chambo Health Centre type B in the period 2022, contributes to the pharmacy ensuring continued access to effective treatments for hypertension, while at the same time ensuring a balance between clinical effectiveness and long-term financial sustainability, considering that patient care and efficient resource management are fundamental pillars of decision-making in a not-for-profit pharmacy, which requires efficient procurement, constant monitoring of consumption and a comprehensive approach to hypertension care at the community level.